3 employees
A preclinical-stage biotechnology company.
2013
$9M
from 4 investors over 4 rounds
Indalo Therapeutics raised $9M on August 2, 2017
Investors: Atlas Venture, Cultivation Capital, Argonautic Ventures and F-Prime Capital Partners